https://observatorio.fm.usp.br/handle/OPI/32392
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | JANDREY, Elisa H. F. | |
dc.contributor.author | MOURA, Ricardo P. | |
dc.contributor.author | ANDRADE, Luciana N. S. | |
dc.contributor.author | MACHADO, Camila L. | |
dc.contributor.author | CAMPESATO, Luiz Felipe | |
dc.contributor.author | LEITE, Katia Ramos M. | |
dc.contributor.author | INOUE, Lilian T. | |
dc.contributor.author | ASPRINO, Paula F. | |
dc.contributor.author | SILVA, Ana Paula M. da | |
dc.contributor.author | BARROS, Alfredo Carlos S. D. de | |
dc.contributor.author | CARVALHO, Andre | |
dc.contributor.author | LIMA, Vladmir C. de | |
dc.contributor.author | CARRARO, Dirce M. | |
dc.contributor.author | BRENTANI, Helena P. | |
dc.contributor.author | CUNHA, Isabela W. da | |
dc.contributor.author | SOARES, Fernando A. | |
dc.contributor.author | PARMIGIANI, Raphael B. | |
dc.contributor.author | CHAMMAS, Roger | |
dc.contributor.author | CAMARGO, Anamaria A. | |
dc.contributor.author | COSTA, Erico T. | |
dc.date.accessioned | 2019-06-26T17:26:26Z | - |
dc.date.available | 2019-06-26T17:26:26Z | - |
dc.date.issued | 2019 | |
dc.identifier.citation | NPJ BREAST CANCER, v.5, article ID 11, 12p, 2019 | |
dc.identifier.issn | 2374-4677 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/32392 | - |
dc.description.abstract | The risk of developing metastatic disease in breast cancer patients is traditionally predictable based on the number of positive axillary lymph nodes, complemented with additional clinicopathological factors. However, since lymph node-negative patients have a 20-30% probability of developing metastatic disease, lymph node information alone is insufficient to accurately assess individual risk. Molecular approaches, such as multigene expression panels, analyze a set of cancer-related genes that more accurately predict the early risk of metastasis and the treatment response. Here, we present N-Myc downstream-regulated gene 4 (NDRG4) epigenetic silencing as a mechanistic biomarker of metastasis in ductal invasive breast tumors. While aberrant NDRG4 DNA hypermethylation is significantly associated with the development of metastatic disease, downregulation of NDRG4 transcription and protein expression is functionally associated with enhanced lymph node adhesion and cell mobility. Here, we show that epigenetic silencing of NDRG4 modulates integrin signaling by assembling beta 1-integrins into large punctate clusters at the leading edge of tumor cells to promote an ""adhesive switch,"" decreasing cell adhesion to fibronectin and increasing cell adhesion and migration towards vitronectin, an important component of human lymph nodes. Taken together, our functional and clinical observations suggest that NDRG4 is a potential mechanistic biomarker in breast cancer that is functionally associated with metastatic disease. | eng |
dc.description.sponsorship | FAPESP-Sao Paulo Research Foundation [2009/53819-1] | |
dc.description.sponsorship | LICR | |
dc.language.iso | eng | |
dc.publisher | SPRINGERNATURE | eng |
dc.relation.ispartof | Npj Breast Cancer | |
dc.rights | restrictedAccess | eng |
dc.subject.other | lymph-node sections | eng |
dc.subject.other | tumor-cell adhesion | eng |
dc.subject.other | extracellular-matrix | eng |
dc.subject.other | potential biomarker | eng |
dc.subject.other | gene | eng |
dc.subject.other | survival | eng |
dc.subject.other | vitronectin | eng |
dc.subject.other | expression | eng |
dc.subject.other | integrins | eng |
dc.subject.other | glioblastoma | eng |
dc.title | NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients | eng |
dc.type | article | eng |
dc.rights.holder | Copyright SPRINGERNATURE | eng |
dc.identifier.doi | 10.1038/s41523-019-0106-x | |
dc.identifier.pmid | 30963110 | |
dc.subject.wos | Oncology | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | JANDREY, Elisa H. F.:Hosp Siriolibanes, Ctr Oncol Mol, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | MOURA, Ricardo P.:LICR, Sao Paulo, Brazil | |
hcfmusp.author.external | CAMPESATO, Luiz Felipe:Hosp Siriolibanes, Ctr Oncol Mol, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | INOUE, Lilian T.:Hosp Siriolibanes, Ctr Oncol Mol, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | ASPRINO, Paula F.:Hosp Siriolibanes, Ctr Oncol Mol, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | SILVA, Ana Paula M. da:LICR, Sao Paulo, Brazil | |
hcfmusp.author.external | BARROS, Alfredo Carlos S. D. de:Hosp Siriolibanes, Dept Mastol, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | CARVALHO, Andre:Hosp Canc Barretos, Barretos, SP, Brazil | |
hcfmusp.author.external | LIMA, Vladmir C. de:Fundacao Antonio Prudente, AC Camargo Canc Ctr, Ctr Int Pesquisa, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | CARRARO, Dirce M.:Fundacao Antonio Prudente, AC Camargo Canc Ctr, Ctr Int Pesquisa, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | CUNHA, Isabela W. da:Hosp Sao Luis, Rede DOR, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | SOARES, Fernando A.:Hosp Sao Luis, Rede DOR, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | PARMIGIANI, Raphael B.:LICR, Sao Paulo, Brazil | |
hcfmusp.author.external | CAMARGO, Anamaria A.:Hosp Siriolibanes, Ctr Oncol Mol, Sao Paulo, SP, Brazil; LICR, Sao Paulo, Brazil | |
hcfmusp.author.external | COSTA, Erico T.:Hosp Siriolibanes, Ctr Oncol Mol, Sao Paulo, SP, Brazil; LICR, Sao Paulo, Brazil | |
hcfmusp.description.articlenumber | 11 | |
hcfmusp.description.volume | 5 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000470038200001 | |
hcfmusp.origem.id | 2-s2.0-85081679067 | |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Aaboea M., 2003, VITR HUMAN BREAST CA, V1638, P72 | eng |
hcfmusp.relation.reference | [Anonymous], 2014, JAMA, V312, P2566, DOI 10.1001/jama.2014.15746 | eng |
hcfmusp.relation.reference | Benesh EC, 2013, MOL BIOL CELL, V24, P3496, DOI 10.1091/mbc.E12-07-0539 | eng |
hcfmusp.relation.reference | Brentani RR, 2005, CRIT REV ONCOL HEMAT, V54, P95, DOI 10.1016/j.critrevonc.2004.12.006 | eng |
hcfmusp.relation.reference | BRODT P, 1990, BREAST CANCER RES TR, V17, P109, DOI 10.1007/BF01806291 | eng |
hcfmusp.relation.reference | BRODT P, 1989, CLIN EXP METASTAS, V7, P343, DOI 10.1007/BF01753685 | eng |
hcfmusp.relation.reference | Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298 | eng |
hcfmusp.relation.reference | Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460 | eng |
hcfmusp.relation.reference | Chen XY, 2017, ONCOTARGET, V8, P8105, DOI 10.18632/oncotarget.14099 | eng |
hcfmusp.relation.reference | Couch FJ, 2017, JAMA ONCOL, V3, P1190, DOI 10.1001/jamaoncol.2017.0424 | eng |
hcfmusp.relation.reference | Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748 | eng |
hcfmusp.relation.reference | Ding WC, 2012, OMICS, V16, P263, DOI 10.1089/omi.2011.0146 | eng |
hcfmusp.relation.reference | Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875 | eng |
hcfmusp.relation.reference | Felding-Habermann B, 2003, CLIN EXP METASTAS, V20, P203, DOI 10.1023/A:1022983000355 | eng |
hcfmusp.relation.reference | Fontenas L, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006459 | eng |
hcfmusp.relation.reference | Geleta B., 2016, J CANC SCI THER, V8, P154 | eng |
hcfmusp.relation.reference | Goldenberg D, 2004, ARCH OTOLARYNGOL, V130, P39, DOI 10.1001/archotol.130.1.39 | eng |
hcfmusp.relation.reference | Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004 | eng |
hcfmusp.relation.reference | Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151 | eng |
hcfmusp.relation.reference | Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107 | eng |
hcfmusp.relation.reference | Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194 | eng |
hcfmusp.relation.reference | Kadiyska T, 2015, WORLD J GASTROENTERO, V21, P10057, DOI 10.3748/wjg.v21.i35.10057 | eng |
hcfmusp.relation.reference | Kisiel JB, 2015, CLIN CANCER RES, V21, P4473, DOI 10.1158/1078-0432.CCR-14-2469 | eng |
hcfmusp.relation.reference | Kisiel JB, 2012, CANCER-AM CANCER SOC, V118, P2623, DOI 10.1002/cncr.26558 | eng |
hcfmusp.relation.reference | KRAMER RH, 1988, CELL TISSUE RES, V252, P367 | eng |
hcfmusp.relation.reference | LaDuca H, 2014, GENET MED, V16, P830, DOI 10.1038/gim.2014.40 | eng |
hcfmusp.relation.reference | Lahlou H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2905 | eng |
hcfmusp.relation.reference | Li SQ, 2013, BRAIN TUMOR PATHOL, V30, P8, DOI 10.1007/s10014-012-0092-2 | eng |
hcfmusp.relation.reference | Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260 | eng |
hcfmusp.relation.reference | Lu HN, 2014, ONCOL LETT, V8, P1751, DOI 10.3892/ol.2014.2413 | eng |
hcfmusp.relation.reference | Toscani AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174230 | eng |
hcfmusp.relation.reference | Maschietto M, 2008, ONCOLOGY-BASEL, V75, P81, DOI 10.1159/000155210 | eng |
hcfmusp.relation.reference | Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131 | eng |
hcfmusp.relation.reference | Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86 | eng |
hcfmusp.relation.reference | Modhukur V, 2018, EPIGENOMICS-UK, V10, P277, DOI 10.2217/epi-2017-0118 | eng |
hcfmusp.relation.reference | Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008 | eng |
hcfmusp.relation.reference | NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007 | eng |
hcfmusp.relation.reference | Paget S., 1889, LANCET, V1, P99 | eng |
hcfmusp.relation.reference | Patel SA, 2017, MOL ONCOL, V11, P79, DOI 10.1016/j.molonc.2016.09.008 | eng |
hcfmusp.relation.reference | Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45 | eng |
hcfmusp.relation.reference | Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200 | eng |
hcfmusp.relation.reference | Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044 | eng |
hcfmusp.relation.reference | REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269 | eng |
hcfmusp.relation.reference | Reyngold M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103896 | eng |
hcfmusp.relation.reference | Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911 | eng |
hcfmusp.relation.reference | Rizwan A, 2015, NPJ BREAST CANCER, V1, DOI 10.1038/npjbcancer.2015.17 | eng |
hcfmusp.relation.reference | Robinson WH, 2013, NAT REV RHEUMATOL, V9, P267, DOI 10.1038/nrrheum.2013.14 | eng |
hcfmusp.relation.reference | Schilling SH, 2009, J BIOL CHEM, V284, P25160, DOI 10.1074/jbc.M109.012484 | eng |
hcfmusp.relation.reference | Schneider G., 2016, J CANC STEM CELL RES, V4, pe1005 | eng |
hcfmusp.relation.reference | Schneider G, 2016, ONCOTARGET, V7, P69829, DOI 10.18632/oncotarget.12003 | eng |
hcfmusp.relation.reference | Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25 | eng |
hcfmusp.relation.reference | Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102 | eng |
hcfmusp.relation.reference | Taddei I, 2003, J MAMMARY GLAND BIOL, V8, P383, DOI 10.1023/B:JOMG.0000017426.74915.b9 | eng |
hcfmusp.relation.reference | Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293 | eng |
hcfmusp.relation.reference | Tawil NJ, 1996, INT J CANCER, V66, P703, DOI 10.1002/(SICI)1097-0215(19960529)66:5<703::AID-IJC20>3.0.CO;2-3 | eng |
hcfmusp.relation.reference | Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819 | eng |
hcfmusp.relation.reference | Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000 | eng |
hcfmusp.relation.reference | Xiao W, 2015, ONCOL LETT, V9, P1383, DOI 10.3892/ol.2014.2815 | eng |
hcfmusp.relation.reference | Yamamoto H, 2011, J BIOL CHEM, V286, P26158, DOI 10.1074/jbc.M111.256446 | eng |
hcfmusp.relation.reference | Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496 | eng |
dc.description.index | PubMed | eng |
hcfmusp.citation.scopus | 8 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCG Artigos e Materiais de Revistas Científicas - FM/MDR Artigos e Materiais de Revistas Científicas - FM/MPS Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - LIM/23 Artigos e Materiais de Revistas Científicas - LIM/24 Artigos e Materiais de Revistas Científicas - LIM/43 Artigos e Materiais de Revistas Científicas - LIM/55 Artigos e Materiais de Revistas Científicas - ODS/03 |
File | Description | Size | Format | |
---|---|---|---|---|
art_JANDREY_NDRG4_promoter_hypermethylation_is_a_mechanistic_biomarker_associated_2019.PDF Restricted Access | publishedVersion (English) | 2.67 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.